APA

Kiechl S., Wittmann J., Giaccari A., Knoflach M., Willeit P., Bozec A., Moschen A. R., Muscogiuri G., Sorice G. P., Kireva T., Summerer M., Wirtz S., Luther J., Mielenz D., Billmeier U., Egger G., Mayr A., Oberhollenzer F., Kronenberg F., Orthofer M., Penninger J. M., Meigs J. B., Bonora E., Tilg H., Willeit J. & Schett G. (20130509). Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. : Nature medicine.

Chicago

Kiechl Stefan, Wittmann Jürgen, Giaccari Andrea, Knoflach Michael, Willeit Peter, Bozec Aline, Moschen Alexander R, Muscogiuri Giovanna, Sorice Gian Pio, Kireva Trayana, Summerer Monika, Wirtz Stefan, Luther Julia, Mielenz Dirk, Billmeier Ulrike, Egger Georg, Mayr Agnes, Oberhollenzer Friedrich, Kronenberg Florian, Orthofer Michael, Penninger Josef M, Meigs James B, Bonora Enzo, Tilg Herbert, Willeit Johann and Schett Georg. 20130509. Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. : Nature medicine.

Harvard

Kiechl S., Wittmann J., Giaccari A., Knoflach M., Willeit P., Bozec A., Moschen A. R., Muscogiuri G., Sorice G. P., Kireva T., Summerer M., Wirtz S., Luther J., Mielenz D., Billmeier U., Egger G., Mayr A., Oberhollenzer F., Kronenberg F., Orthofer M., Penninger J. M., Meigs J. B., Bonora E., Tilg H., Willeit J. and Schett G. (20130509). Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. : Nature medicine.

MLA

Kiechl Stefan, Wittmann Jürgen, Giaccari Andrea, Knoflach Michael, Willeit Peter, Bozec Aline, Moschen Alexander R, Muscogiuri Giovanna, Sorice Gian Pio, Kireva Trayana, Summerer Monika, Wirtz Stefan, Luther Julia, Mielenz Dirk, Billmeier Ulrike, Egger Georg, Mayr Agnes, Oberhollenzer Friedrich, Kronenberg Florian, Orthofer Michael, Penninger Josef M, Meigs James B, Bonora Enzo, Tilg Herbert, Willeit Johann and Schett Georg. Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. : Nature medicine. 20130509.